Document is current
Any future updates will be listed below
-
Authors
Ismailani, Uzair S. https://orcid.org/0000-0001-5102-6102
Buchler, Ariel https://orcid.org/0000-0002-4016-032X
de Carvalho Tso, Jadde
Pulente, Serena M. https://orcid.org/0000-0002-4837-6790
Abdirahman, Faduma https://orcid.org/0000-0002-8396-1186
Hoddinott, Emily L. https://orcid.org/0009-0003-0355-9184
Fortier, Megan
Mulvihill, Erin E. https://orcid.org/0000-0002-3981-0241
deKemp, Robert A.
Rotstein, Benjamin H. https://orcid.org/0000-0001-9707-9357
-
Funding
Funding for this research was provided by:
Heart and Stroke Foundation of Canada (G-23-0035462)
Canada Foundation for Innovation (39358)
- License Information
-
More Information
Article History
Received: 18 September 2025
Accepted: 17 November 2025
First Online: 20 December 2025
Declarations
:
: All housing, handling, and experimental procedures were in strict accordance with the guidelines of the Canadian Council on Animal Care and with the approval of the University of Ottawa Animal Care Committee (HI-2927, HIe-3918).
: RAdK receives royalties from Rubidium PET technologies licensed to Jubilant Radiopharma and INVIA Medical Solutions; and received unrestricted research grant funding or honoraria from Siemens Molecular Imaging, IONETIX and Jubilant Radiopharma. BHR receives royalties from Innervate Radiopharmaceuticals. All other authors report no competing interests.
